CRYPTOCOCCAL MENINGITIS
Clinical trials for CRYPTOCOCCAL MENINGITIS explained in plain language.
Never miss a new study
Get alerted when new CRYPTOCOCCAL MENINGITIS trials appear
Sign up with your email to follow new studies for CRYPTOCOCCAL MENINGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope against a 100% fatal brain infection: massive trial launches
Disease control Recruiting nowThis study tests new drug combinations for cryptococcal meningitis, a brain infection that is always fatal without treatment and still kills many people with HIV. The trial aims to find safer and more effective therapies by comparing several new antifungal regimens. About 2,000 a…
Matched conditions: CRYPTOCOCCAL MENINGITIS
Phase: PHASE2, PHASE3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated May 26, 2026 04:13 UTC
-
One-Dose wonder: could a single shot stop a deadly brain infection?
Disease control Recruiting nowThis study looks at whether giving a single, stronger dose of antifungal medicine (liposomal amphotericin) along with the standard drug (fluconazole) can prevent cryptococcal meningitis in people with HIV who test positive for the fungus but have no symptoms. About 356 adults in …
Matched conditions: CRYPTOCOCCAL MENINGITIS
Phase: PHASE2, PHASE3 • Sponsor: Makerere University • Aim: Disease control
Last updated May 26, 2026 03:56 UTC
-
Healthy adults with rare fungal infection sought for landmark study
Knowledge-focused Recruiting nowThis study looks at healthy adults who get a rare fungal infection called cryptococcosis. Researchers want to learn why some healthy people get this infection and how their bodies react. Up to 800 adults over 18 with confirmed cryptococcosis can join. No new treatments are tested…
Matched conditions: CRYPTOCOCCAL MENINGITIS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 26, 2026 03:54 UTC
-
Scientists track rare immune disease to uncover its secrets
Knowledge-focused Recruiting nowThis study follows people with idiopathic CD4+ lymphocytopenia (ICL), a rare condition where the body has too few CD4+ immune cells, raising the risk of serious infections. Researchers aim to learn how the disease progresses, what causes it, and how it affects the body over time.…
Matched conditions: CRYPTOCOCCAL MENINGITIS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC